4-Bromo-2-nitrobenzoic acid | CAS:99277-71-1

We serve 4-Bromo-2-nitrobenzoic acid CAS:99277-71-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Bromo-2-nitrobenzoic acid

Chemical Name:4-Bromo-2-nitrobenzoic acid
CAS.NO:99277-71-1
Synonyms:4-Bromo-2-nitrobenzoic acid
4-Bromo-2-nitrobenzoicacid
Benzoic acid, 4-bromo-2-nitro-
2-nitro-4-bromobenzoic acid
4-Brom-2-nitro-benzoesaeure
Molecular Formula:C7H4BrNO4
Molecular Weight:246.01500
 
Physical and Chemical Properties:
Density:1.892
Melting point:165-169ºC
Boiling point:368.6ºC
Flash point:176.7ºC
 
Specification:
Appearance:Off-white to pale yellow powder
Assay:≥98.0%
Moisture:≤0.2%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 4-Bromo-2-nitrobenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Brom-2-nitro-benzoesaeure physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzoic acid, 4-bromo-2-nitro- Use and application,2-nitro-4-bromobenzoic acid technical grade,usp/ep/jp grade.


Related News: The insulin-only and bihormonal configurations may be helpful in diabetes.2-Methoxy-5-methyl-N,N-bis(1-methylethyl)-3-phenylbenzenepropanamine fumarate manufacturer Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.(R)-3-Aminobutan-1-ol supplier The risk to the general public remains low. And we continue to be confident we are in a good position to respond to this developing situation.”1-Bromo-8-chloronaphthalene vendor Cost: Hedge prices of thick product lines + self-produced intermediates fluctuate, and sufficient supply of upstream raw materials can significantly promote the production of APIs.In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers.